
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations
Daniel J. Panyard, Kyeong Mo Kim, Burcu F. Darst, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 87
Daniel J. Panyard, Kyeong Mo Kim, Burcu F. Darst, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
Zhiqiang Pang, Jasmine Chong, Guangyan Zhou, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. W1, pp. W388-W396
Open Access | Times Cited: 3273
Zhiqiang Pang, Jasmine Chong, Guangyan Zhou, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. W1, pp. W388-W396
Open Access | Times Cited: 3273
The metabolomics of human aging: Advances, challenges, and opportunities
Daniel J. Panyard, Bing Yu, M Snyder
Science Advances (2022) Vol. 8, Iss. 42
Open Access | Times Cited: 91
Daniel J. Panyard, Bing Yu, M Snyder
Science Advances (2022) Vol. 8, Iss. 42
Open Access | Times Cited: 91
Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations
Elena V. Feofanova, Michael R. Brown, Taryn Alkis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Elena V. Feofanova, Michael R. Brown, Taryn Alkis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
Daniel J. Panyard, Justin McKetney, Yuetiva Deming, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5447-5470
Open Access | Times Cited: 26
Daniel J. Panyard, Justin McKetney, Yuetiva Deming, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5447-5470
Open Access | Times Cited: 26
The genomic alterations in glioblastoma influence the levels of CSF metabolites
Daniel H. Wang, Yoko Fujita, Antonio Dono, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Daniel H. Wang, Yoko Fujita, Antonio Dono, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes
Lianne M. Reus, Toni Boltz, Marcelo Francia, et al.
Molecular Psychiatry (2025)
Open Access | Times Cited: 1
Lianne M. Reus, Toni Boltz, Marcelo Francia, et al.
Molecular Psychiatry (2025)
Open Access | Times Cited: 1
Advances in mass spectrometry-based multi-scale metabolomic methodologies and their applications in biological and clinical investigations
Ziyi Wang, Hongying Zhu, Wei Xiong
Science Bulletin (2023) Vol. 68, Iss. 19, pp. 2268-2284
Open Access | Times Cited: 21
Ziyi Wang, Hongying Zhu, Wei Xiong
Science Bulletin (2023) Vol. 68, Iss. 19, pp. 2268-2284
Open Access | Times Cited: 21
GWAS Central: an expanding resource for finding and visualising genotype and phenotype data from genome-wide association studies
Tim Beck, Thomas Rowlands, Tom Shorter, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D986-D993
Open Access | Times Cited: 26
Tim Beck, Thomas Rowlands, Tom Shorter, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D986-D993
Open Access | Times Cited: 26
Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS)
James N. Baraniuk
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
James N. Baraniuk
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Comment on “Neurotrophin-3 as a mediator in the link between PM2.5 exposure and psychiatric disorders: A Mendelian randomization study”
Xiaoyang Zhu, Kuo Wang, Shuaiqi Zhang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 293, pp. 118037-118037
Open Access
Xiaoyang Zhu, Kuo Wang, Shuaiqi Zhang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 293, pp. 118037-118037
Open Access
Genome-wide metabolite quantitative trait loci analysis (mQTL) in red blood cells from volunteer blood donors
Amy Moore, Michael P. Busch, Karolina H. Dziewulska, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102706-102706
Open Access | Times Cited: 22
Amy Moore, Michael P. Busch, Karolina H. Dziewulska, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102706-102706
Open Access | Times Cited: 22
CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
Ruocheng Dong, Qiongshi Lu, Hyunseung Kang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
Ruocheng Dong, Qiongshi Lu, Hyunseung Kang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
Critical Factors in Sample Collection and Preparation for Clinical Metabolomics of Underexplored Biological Specimens
Hygor M. R. de Souza, Tássia Tatiane Pontes Pereira, Hanna C. de Sá, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 36-36
Open Access | Times Cited: 4
Hygor M. R. de Souza, Tássia Tatiane Pontes Pereira, Hanna C. de Sá, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 36-36
Open Access | Times Cited: 4
Brain development and bioenergetic changes
Arjun Rajan, Ryann M. Fame
Neurobiology of Disease (2024) Vol. 199, pp. 106550-106550
Open Access | Times Cited: 4
Arjun Rajan, Ryann M. Fame
Neurobiology of Disease (2024) Vol. 199, pp. 106550-106550
Open Access | Times Cited: 4
Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study
Yilong Lin, Yue Zhang, Songsong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Yilong Lin, Yue Zhang, Songsong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Causal Association Between Cerebrospinal Fluid Metabolites and Parkinson's Disease: A Two-Sample Bidirectional Mendelian Randomization Study
Jing Liao, Liangyan Jiang, Yiliu Qin, et al.
Behavioural Brain Research (2025), pp. 115426-115426
Closed Access
Jing Liao, Liangyan Jiang, Yiliu Qin, et al.
Behavioural Brain Research (2025), pp. 115426-115426
Closed Access
The identification of plasma and cerebrospinal fluid metabolites causally associated with mental disorders from a genetic perspective
Yanhong Song, Xiaodong Wu, Ziyi Wu, et al.
Journal of Affective Disorders (2025) Vol. 373, pp. 438-448
Closed Access
Yanhong Song, Xiaodong Wu, Ziyi Wu, et al.
Journal of Affective Disorders (2025) Vol. 373, pp. 438-448
Closed Access
Genetically Confirmed Optimal Causal Association of Cerebrospinal Fluid Metabolites With Hemorrhagic Stroke
Yingjie Shen, Yaolou Wang, Yang Shen, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 1
Closed Access
Yingjie Shen, Yaolou Wang, Yang Shen, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 1
Closed Access
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective
Ziyi Wang, Hongying Zhu, Wei Xiong
Frontiers of Medicine (2025)
Closed Access
Ziyi Wang, Hongying Zhu, Wei Xiong
Frontiers of Medicine (2025)
Closed Access
Roles of cerebrospinal fluid metabolites in mediating the relationship between cathepsins and narcolepsy type 1: A comprehensive Mendelian randomization analysis
Yanjuan Wu, Qiming Gan, Xiaofen Su, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 137, pp. 111263-111263
Closed Access
Yanjuan Wu, Qiming Gan, Xiaofen Su, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 137, pp. 111263-111263
Closed Access
Decoding the Therapeutic Target SVEP1: Harnessing Molecular Trait GWASs to Unravel Mechanisms of Human Disease
Jared S. Elenbaas, Paul C. Lee, Ved Patel, et al.
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 131-148
Closed Access
Jared S. Elenbaas, Paul C. Lee, Ved Patel, et al.
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 131-148
Closed Access
In-Depth Investigation on Potential Mechanism of Forest-Grown Ginseng Alleviating Alzheimer’s Disease via UHPLC-MS-Based Metabolomics
Huazhou Niu, Meng Zhang, Kaiyue Zhang, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 93-93
Open Access
Huazhou Niu, Meng Zhang, Kaiyue Zhang, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 93-93
Open Access
The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
Rong Peng, Xiaoxin Wang, Wei Wang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Rong Peng, Xiaoxin Wang, Wei Wang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Burden of Dementia Due to Stroke Subtypes: A Study Integrating the GBD Database and Mendelian Randomization
Meng Jin, Jingjing Liu, Zhijun Bao, et al.
(2025)
Closed Access
Meng Jin, Jingjing Liu, Zhijun Bao, et al.
(2025)
Closed Access
From Clinic to Mechanisms: Multi-Omics Provide New Insights into Cerebrospinal Fluid Metabolites and the Spectrum of Psychiatric Disorders
Jie Wen, Yingjie Li, Yu Chen, et al.
Molecular Neurobiology (2025)
Closed Access
Jie Wen, Yingjie Li, Yu Chen, et al.
Molecular Neurobiology (2025)
Closed Access